Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
PHASE2
The purpose of this study is to evaluate the effectiveness and safety of th...
Research on Effectiveness and Safety of the Treatment, Hyperthermic Intraperitoneal Chemotherapy Combined With Tislelizumab and Targeted Therapy, That is Used for High-risk Hepatocellular Carcinoma After R0 Resection
NA
There are limited treatment options for HCC with high recurrence risk, and ...
Status
Unknown
Location
Hunan Provincial People's Hospital(The First Affiliated Hospital of Hunan Normal University)
An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and Olaparib for Neoadjuvant Therapy in HRD-positive Advanced Ovarian Cancer
PHASE2
The R0 resection rate in neoadjuvant chemotherapy for advanced ovarian canc...